Back to Search
Start Over
Long‐term first‐in‐man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high‐risk prostate cancer after radical prostatectomy.
- Source :
- Prostate; Feb2022, Vol. 82 Issue 2, p245-253, 9p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 02704137
- Volume :
- 82
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Prostate
- Publication Type :
- Academic Journal
- Accession number :
- 154219050
- Full Text :
- https://doi.org/10.1002/pros.24267